Effects of transient overexpression or knockdown of cytochrome P450 reductase on reactive oxygen species generation and hypoxia reoxygenation injury in liver cells

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 12, 2011, Pages 846-853

  Pillai, Venkateswaran C ^a   Snyder, Russell O ^a   Gumaste, Upendra ^a   Thekkumkara, Thomas J ^a   Mehvar, Reza ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cytochrome P450 reductase; Hepatic ischaemia reperfusion injury; HepG2 cells; Oxidative stress; Rat liver epithelial cells; Reactive oxygen species

Indexed keywords

CYTOCHROME P450 REDUCTASE; PLASMID DNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL STRAIN HEPG2; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; LIVER CELL; LIVER CELL DAMAGE; LIVER ISCHEMIA; NONHUMAN; RAT; REOXYGENATION; REPERFUSION INJURY;

ANIMALS; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RNA, SMALL INTERFERING;

EID: 82355194925     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05622.x     Document Type: Article

References (41)

1. Horecker BL. Triphosphopyridine nucleotide-cytochrome c reductase in liver. J. Biol. Chem. 1950; 183: 593-605.
2. Williams CH Jr, Kamin H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J. Biol. Chem. 1962; 237: 587-95.
3. Zangar RC, Davydov DR, Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 2004; 199: 316-31.
4. Davydov DR. Microsomal monooxygenase in apoptosis: Another target for cytochrome c signaling? Trends Biochem. Sci. 2001; 26: 155-60.
5. Winston GW, Feierman DE, Cederbaum AI. The role of iron chelates in hydroxyl radical production by rat liver microsomes, NADPH-cytochrome P-450 reductase and xanthine oxidase. Arch. Biochem. Biophys. 1984; 232: 378-90.
6. Bosterling B, Trudell JR. Spin trap evidence for production of superoxide radical anions by purified NADPH-cytochrome P-450 reductase. Biochem. Biophys. Res. Commun. 1981; 98: 569-75.
7. Morehouse LA, Thomas CE, Aust SD. Superoxide generation by NADPH-cytochrome P-450 reductase: The effect of iron chelators and the role of superoxide in microsomal lipid peroxidation. Arch. Biochem. Biophys. 1984; 232: 366-77.
8. Bachur NR, Gordon SL, Gee MV, Kon H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA 1979; 76: 954-7.
9. Heine T, Glatt H, Epe B. Human cytochrome P450 reductase can act as a source of endogenous oxidative DNA damage and genetic instability. Free Radic. Biol. Med. 2006; 40: 801-7.
10. Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann. Transplant. 2004; 9: 81-3.
11. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br. J. Surg. 2010; 97: 1461-75.
12. Pillai VC, Mehvar R. Inhibition of NADPH-cytochrome P450 reductase by tannic acid in rat liver microsomes and primary hepatocytes:Methodological artifacts and application to ischemia-reperfusion injury. J. Pharm. Sci. 2011; 100: 3495-505.
13. Lopes GK, Schulman HM, Hermes-Lima M. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions. Biochim. Biophys. Acta 1999; 1472: 142-52.
14. Tsao MS, Smith JD, Nelson KG, Grisham JW. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp. Cell Res. 1984; 154: 38-52.
15. Krishna SB, Alfonso LF, Thekkumkara TJ, Abbruscato TJ, Bhat GJ. Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells. Arch. Biochem. Biophys. 2007; 457: 16-28.
16. Lerche C, Le Jossic C, Fautrel A et al. Rat liver epithelial cells express functional cytochrome P450 2E1. Carcinogenesis 1996; 17: 1101-6.
17. Wilkening S, Stahl F, Bader A. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab. Dispos. 2003; 31: 1035-42.
18. Gonzalez FJ, Korzekwa KR. Cytochromes P450 expression systems. Annu. Rev. Pharmacol. Toxicol. 1995; 35: 369-90.
19. Phillips AH, Langdon RG. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterisation, and kinetic studies. J. Biol. Chem. 1962; 237: 2652-60.
20. Terui K, Enosawa S, Haga S et al. Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD. J. Hepatol. 2004; 41: 957-65.
21. Qian T, Nieminen AL, Herman B, Lemasters JJ. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am. J. Physiol. 1997; 273: C1783-92.
22. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 2004; 39: 1533-43.
23. Nieminen AL, Gores GJ, Bond JM, Imberti R, Herman B, Lemasters JJ. A novel cytotoxicity screening assay using a multiwell fluorescence scanner. Toxicol. Appl. Pharmacol. 1992; 115: 147-55.
24. Sattler R, Charlton MP, Hafner M, Tymianski M. Determination of the time course and extent of neurotoxicity at defined temperatures in cultured neurons using a modified multiwell plate fluorescence scanner. J. Cereb. Blood Flow Metab. 1997; 17: 455-63.
25. Ludbrook J. On making multiple comparisons in clinical and experimental pharmacology and physiology. Clin. Exp. Pharmacol. Physiol. 1991; 18: 379-92.
26. Ludbrook J. Linear regression analysis for comparing two measurers or methods of measurement: But which regression? Clin. Exp. Pharmacol. Physiol. 2010; 37: 692-9.
27. Jaeschke H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J. Invest. Surg. 2003; 16: 127-40.
28. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J. Surg. Res. 2008; 147: 153-9.
29. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: A review. Liver Transpl. 2005; 11: 1031-47.
30. de Groot H, Brecht M. Reoxygenation injury in rat hepatocytes: Mediation by O2/H2O2 liberated by sources other than xanthine oxidase. Biol. Chem. Hoppe Seyler 1991; 372: 35-41.
31. Nordstrom G, Seeman T, Hasselgren PO. Beneficial effect of allopurinol in liver ischemia. Surgery 1985; 97: 679-84.
32. Adkison D, Hollwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol. Scand. Suppl. 1986; 548: 101-7.
33. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007; 39: 44-84.
34. Schmalix WA, Lang D, Schneider A, Bocker R, Greim H, Doehmer J. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: Sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines. Drug Metab. Dispos. 1996; 24: 1314-9.
35. Martinez VG, Williams KJ, Stratford IJ, Clynes M, O'Connor R. Overexpression of cytochrome P450 NADPH reductase sensitises MDA 231 breast carcinoma cells to 5-fluorouracil: Possible mechanisms involved. Toxicol. In Vitro 2008; 22: 582-8.
36. Wang Y, Gray JP, Mishin V, Heck DE, Laskin DL, Laskin JD. Role of cytochrome P450 reductase in nitrofurantoin-induced redox cycling and cytotoxicity. Free Radic. Biol. Med. 2008; 44: 1169-79.
37. Baumann RP, Hodnick WF, Seow HA et al. Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells. Cancer Res. 2001; 61: 7770-6.
38. Ramji S, Lee C, Inaba T, Patterson AV, Riddick DS. Human NADPH-cytochrome P450 reductase overexpression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines. Cancer Res. 2003; 63: 6914-9.
39. Feidt DM, Klein K, Nussler A, Zanger UM. RNA-interference approach to study functions of NADPH-cytochrome P450 oxidoreductase in human hepatocytes. Chem. Biodivers. 2009; 6: 2084-91.
40. Shiraki H, Guengerich FP. Turnover of membrane proteins: Kinetics of induction and degradation of seven forms of rat liver microsomal cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydrolase. Arch. Biochem. Biophys. 1984; 235: 86-96.
41. Grant MH, Melvin MA, Shaw P, Melvin WT, Burke MD. Studies on the maintenance of cytochromes P-450 and b5, monooxygenases and cytochrome reductases in primary cultures of rat hepatocytes. FEBS Lett. 1985; 190: 99-103.